Art

J-GLOBAL ID：201702252911720110   Reference number：17A1007165

Coronary Artery Disease and Type 2 Diabetes Mellitus Current Treatment Strategies and Future Perspective

冠動脈疾患と2型糖尿病 最新の治療戦略と将来的展望

Author (2)： Naito Ryo (Heart Center, Juntendo University Urayasu Hospital) ,  Miyauchi Katsumi (Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine)
Material： International Heart Journal  (Int Heart J)
Volume： 58  Issue： 4  Page： 475-480(J-STAGE)  Publication year： 2017 
JST Material Number： Z0752A  ISSN： 1349-2365  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *coronary artery disease ,...
Semi thesaurus term： Preemptive medicine

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1007165&from=J-GLOBAL&jstjournalNo=Z0752A") }}

Author keywords (5)： Multivessel disease ,  Revascularization ,  SGLT2 inhibitor ,  GLP1 antagonist ,  Comprehensive risk management

JST classification (2)： Treatment for cardiovasular system diseases in general  (GJ05010B) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Reference (39)：

• 1. Center for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. Available at: https://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf Accessed May 12, 2017.
• 2. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 2000; 36: 355-65. (Review)
• 3. Norhammar A, Malmberg K, Diderholm E, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 2004; 43: 585-91.
• 4. Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003; 108: 1527-32. (Review)
• 5. Dagenais GR, Lu J, Faxon DP, et al; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation 2011; 123: 1492-500.

Terms in the title (5)： 冠動脈疾患 ,  2型糖尿病 ,  治療戦略 ,  将来 ,  展望